Physician Resource Center
Specialties
Featured Content View More
Advances in Ovarian Cancer Treatment Show Promise for Longer Response, Survival Rates
While it remains the leading cause of death among patients with gynecologic cancers, new treatments are offering patients better outcomes and better quality of life.
Graft Versus Host Disease No Longer Poses High Risk to Transplant Patients
Graft versus host disease (GVHD) used to present such a risk to transplant patients, an estimate 10-15% of patients would develop a fatal case of it.
Clinical Trial Utilizes Novel CAR Target for Relapsed/Refractory Multiple Myeloma
Most multiple myeloma patients with relapsed/refractory disease will undergo CAR T-cell therapy targeting B-cell maturation antigen (BCMA), a protein found on multiple myeloma cells.
Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma
While multiple myeloma affects mostly older adults — 95% are over 50 Kenan Onel, MD, and his colleagues discovered that patients whose BRCA genes contained PGVs, which dramatically increase cancer risk, were more likely to be diagnosed ...
Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park
Congressman Kennedy announced $7,731,872 in funding for the Roswell Park Comprehensive Cancer Center to renovate its newly integrated biobank, the Roswell Park Biorepository, made possible through the Office of the Director of the National ...
The Clinical Leukemia Service at Roswell Park Comprehensive Cancer Center helped lead the first clinical trial of the experimental oral drug ziftomenib in patients with acute myeloid leukemia (AML).
Featured CMEs
This site is intended for healthcare professionals
Roswell Park News
Roswell Park Experts to Showcase Groundbreaking Hematology Research at 66th ASH Annual Meeting
Tuesday, November 19, 2024 2:11 PM
Monday, November 18, 2024 8:53 AM
Roswell Park Team Members Recognized for Exceptional Support to First Responders
Friday, November 15, 2024 9:53 AM